Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Caredx Inc (CDNA)

Caredx Inc (CDNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 908,572
  • Shares Outstanding, K 51,216
  • Annual Sales, $ 379,810 K
  • Annual Income, $ -21,350 K
  • EBIT $ -31 M
  • EBITDA $ -9 M
  • 60-Month Beta 2.52
  • Price/Sales 2.41
  • Price/Cash Flow N/A
  • Price/Book 3.04

Options Overview Details

View History
  • Implied Volatility 224.22% (+68.86%)
  • Historical Volatility 48.07%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 224.22% on 03/10/26
  • IV Low 53.41% on 05/21/25
  • Expected Move (DTE 10) 2.17 (12.77%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 16
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 404
  • Open Int (30-Day) 1,486
  • Expected Range 14.81 to 19.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.03
  • Number of Estimates 2
  • High Estimate -0.02
  • Low Estimate -0.04
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +84.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.94 +0.24%
on 03/10/26
21.00 -19.14%
on 02/11/26
-3.59 (-17.45%)
since 02/10/26
3-Month
16.94 +0.24%
on 03/10/26
21.49 -20.97%
on 01/22/26
-2.57 (-13.15%)
since 12/10/25
52-Week
10.96 +54.93%
on 07/17/25
21.49 -20.97%
on 01/22/26
-1.11 (-6.14%)
since 03/10/25

Most Recent Stories

More News
CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets

First-of-its-kind, cloud-native AI platform for transplant program cohort analysis, clinical research, and real-world evidence generation announced at the 2026 Precision Medicine World Conference

CDNA : 16.98 (-4.28%)
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...

CDNA : 16.98 (-4.28%)
CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer

Kennedy brings seven years of public company CFO experience

CDNA : 16.98 (-4.28%)
CareDx: Q4 Earnings Snapshot

CareDx: Q4 Earnings Snapshot

CDNA : 16.98 (-4.28%)
CareDx Announces Fourth Quarter and Full Year 2025 Financial Results

Full Year 2025 Total Revenue of $380 Million Increased 14% Year-Over-Year Expects Full Year 2026 Revenue of $420 Million to $444 Million

CDNA : 16.98 (-4.28%)
CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare...

CDNA : 16.98 (-4.28%)
CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy

AlloHeme Identified Cancer Relapse Earlier Than Standard Monitoring Methods in AML and MDS Patients Following Allogeneic HCT Ultra‑Sensitive, Non‑Invasive Surveillance...

CDNA : 16.98 (-4.28%)
CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare...

CDNA : 16.98 (-4.28%)
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings

Company to host investor webcast and conference call on February 12 at 7 a.m. PT / 10 a.m. ET Investor webcast will feature the clinical validation...

CDNA : 16.98 (-4.28%)
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference 

CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company™ —, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value...

CDNA : 16.98 (-4.28%)

Business Summary

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of...

See More

Key Turning Points

3rd Resistance Point 18.38
2nd Resistance Point 18.09
1st Resistance Point 17.53
Last Price 16.98
1st Support Level 16.68
2nd Support Level 16.39
3rd Support Level 15.83

See More

52-Week High 21.49
Fibonacci 61.8% 17.46
Last Price 16.98
Fibonacci 50% 16.22
Fibonacci 38.2% 14.98
52-Week Low 10.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar